We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Apotex Warning Letter Casts Doubt on Company’s Process Controls
Apotex Warning Letter Casts Doubt on Company’s Process Controls
March 22, 2013
An imprecise media fill protocol and poor probes into speckled tablets have landed Apotex a warning letter in which the FDA questions the heft of the generic-drug maker’s process controls.